Pakistan Unveils Ambitious Mobile Manufacturing Policy 2026-30 To Become Regional Electronics Hub
Pakistan finalizes Mobile and Electronics Manufacturing Policy 2026-30 targeting 50% local component production, $700 mi...
Read More →Pakistan finalizes Mobile and Electronics Manufacturing Policy 2026-30 targeting 50% local component production, $700 mi...
Read More →In 2026, in vivo gene therapies and CRISPR cures for rare diseases are becoming standard care, highlighted by vision res...
Read More →The FDA has qualified its first AI tool for clinical trials in 2026, validating the use of multimodal models and digital...
Read More →Next-generation CAR-T therapies, including KIR-CAR and armored cells secreting IL-12, are breaking into solid tumors by ...
Read More →Building on the Nobel Prize-winning discovery of Regulatory T Cells, 2026 research focuses on harnessing the gut microbi...
Read More →Senolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targeting senescent "zombie ...
Read More →Neuralink has received FDA Breakthrough Device Designation for its speech restoration BCI technology, aiming to translat...
Read More →GLP-1 medications in 2026 are transforming from weight-loss drugs to essential cardiovascular and renal therapies. With ...
Read More →Moderna and Merck's 5-year follow-up data for the personalized mRNA cancer vaccine intismeran autogene shows a sustained...
Read More →The 2026 Alzheimer's pipeline features 192 clinical trials, highlighted by the FDA approval of subcutaneous Leqembi and ...
Read More →The CRISPR clinical landscape in 2026 has expanded to over 250 active trials, moving beyond sickle cell disease into in ...
Read More →The Dyson AirPurifier Wearable Gen 2 introduces a silent, zero-resistance electrostatic filtration system and a Neural E...
Read More →